$3Bn+ PORTFOLIO VALUE CREATED   .
SEED TO SERIES A . DEEP TECH FOCUS   .
EVERY PITCH GETS A RESPONSE WITHIN 10 DAYS   .
SEED TO SERIES A . DEEP TECH FOCUS   .
$3Bn+ PORTFOLIO VALUE CREATED   .
SEED TO SERIES A . DEEP TECH FOCUS   .
EVERY PITCH GETS A RESPONSE WITHIN 10 DAYS   .
$3Bn+ PORTFOLIO VALUE CREATED   .
SEED TO SERIES A . DEEP TECH FOCUS   .
EVERY PITCH GETS A RESPONSE WITHIN 10 DAYS   .
SEED TO SERIES A . DEEP TECH FOCUS   .
$3Bn+ PORTFOLIO VALUE CREATED   .
SEED TO SERIES A . DEEP TECH FOCUS   .
EVERY PITCH GETS A RESPONSE WITHIN 10 DAYS   .
INSIGHTS · RESEARCH · INTELLIGENCE

Resources

Field notes from building India's next decade — research, conversations and case studies on the founders, sectors and ideas shaping the country's tech future.
Pinned

The Quantum Readiness Index —  India on the global curve

Published
22 October 2024
Lenght
32 Pages
Author
UIV Research Team
Healthcare
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Fintech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Deep Tech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Cybersecurity
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Manufacturing
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Travel
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Healthcare
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Fintech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Healthcare
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Healthcare
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Fintech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
Fintech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Deep Tech
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Cybersecurity
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Manufacturing
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
Travel
InfiNano

Democratizing cancer therapy via gold-nanoliposome PTT – reducing treatment cost from ₹4,00,000 to ₹10,000. Partnerships with Tata...

40x
COST REDUCTION
The Portfolio Runs Deeper

Case studies capture a moment. Behind them are 50+ companies across 12 sectors – each backed with the same conviction.

VIEW ALL PORTFOLIO COMPANIES
STAY CURRENT

New research, straight to you.

Every new report and sector brief delivered to your inbox — no noise, just signal. Unsubscribe any time.

Oops! Something went wrong while submitting the form.
INVESTOR LOGIN
PARTNER LOGIN
SUBMIT YOUR PITCH